Skip to main content Help with accessibility Skip to main navigation

BRIVARACETAM tablets and oral solution (Briviact®▼)

CCG Approval Status:

Date Added: 02 - Oct - 2018
Body System:
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of BRIVARACETAM tablets/oral solution (Briviact®▼) for adjunctive treatment of focal seizures following initiation by a consultant neurologist.

AMBER patient retained by specialist NHS Wirral CCG